Research programme: age-related disease therapeutics - Calico
Latest Information Update: 22 Nov 2022
At a glance
- Originator Calico
- Developer Calico; Terray Therapeutics
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified